|
|
Exchange: |
N/A |
Security
Type: |
Common |
Shares
Out: |
251,510,000 |
Market
Cap: |
136.28(B) |
Last
Volume: |
0 |
Avg
Vol: |
0 |
52
Week Range: |
$414.13 - $547.8 |
|
Level
I Sector: |
N/A |
Level
II Sector: |
N/A |
Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : 17 |
Guru Rank Value : 22.1 |
Guru Occurances : 4 |
|
|
|
|
|
|
|
Company Profile Elevance Health is an insurance holding company. Co. is a health benefits company, serving medical members through its affiliated health plans. Co. has four segments: Commercial and Specialty Business, which provides fully-insured health products, managed care services; Government Business, which includes Medicare and Medicaid businesses, its subsidiary, National Government Services, and services provided to the federal government in connection with its Federal Health Products and Services business; IngenioRx, which includes its pharmacy benefit management business; and Other, which includes Diversified Business Group, which is its integrated health services business.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
0 |
0 |
Total Buy Value |
$0 |
$0 |
$0 |
$0 |
Total People Bought |
0 |
0 |
0 |
0 |
Total Buy Transactions |
0 |
0 |
0 |
0 |
Total Shares Sold |
20,310 |
45,506 |
52,427 |
69,839 |
Total Sell Value |
$10,832,155 |
$23,439,266 |
$26,775,666 |
$34,560,221 |
Total People Sold |
1 |
5 |
7 |
8 |
Total Sell Transactions |
2 |
6 |
10 |
12 |
End Date |
2024-03-31 |
2023-12-29 |
2023-06-30 |
2022-06-30 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Dixon Robert L Jr |
Director |
|
2022-06-06 |
4 |
S |
$497.14 |
$208,799 |
D/D |
(420) |
9,491 |
|
5% |
|
Peru Ramiro G |
Director |
|
2022-05-19 |
4 |
AS |
$468.88 |
$464,191 |
D/D |
(990) |
9,405 |
|
-5% |
|
Jallal Bahija |
Director |
|
2022-05-18 |
4 |
A |
$0.00 |
$0 |
D/D |
440 |
3,342 |
|
- |
|
Dixon Robert L Jr |
Director |
|
2022-05-18 |
4 |
A |
$0.00 |
$0 |
D/D |
440 |
9,911 |
|
- |
|
Peru Ramiro G |
Director |
|
2022-05-18 |
4 |
A |
$0.00 |
$0 |
D/D |
440 |
10,395 |
|
- |
|
Schneider Ryan M. |
Director |
|
2022-05-18 |
4 |
A |
$0.00 |
$0 |
D/D |
440 |
5,154 |
|
- |
|
Devore Susan D. |
Director |
|
2022-05-18 |
4 |
A |
$0.00 |
$0 |
D/D |
440 |
856 |
|
- |
|
Clark R Kerry |
Director |
|
2022-05-18 |
4 |
A |
$0.00 |
$0 |
D/D |
440 |
8,194 |
|
- |
|
Hay Lewis III |
Director |
|
2022-05-18 |
4 |
A |
$0.00 |
$0 |
D/D |
440 |
10,061 |
|
- |
|
Neri Antonio F |
Director |
|
2022-05-18 |
4 |
A |
$0.00 |
$0 |
D/D |
440 |
3,479 |
|
- |
|
Tallett Elizebeth E |
Director |
|
2022-05-18 |
4 |
A |
$0.00 |
$0 |
D/D |
440 |
9,446 |
|
- |
|
Haytaian Peter D |
EVP & Pres., DBG & IngenioRx |
|
2022-03-10 |
4 |
AS |
$458.68 |
$8,155,863 |
D/D |
(17,703) |
12,161 |
|
-3% |
|
Haytaian Peter D |
EVP & Pres., DBG & IngenioRx |
|
2022-03-10 |
4 |
OE |
$131.80 |
$243,566 |
D/D |
1,848 |
29,864 |
|
- |
|
Penczek Ronald W |
CAO & Controller |
|
2022-03-03 |
4 |
S |
$463.68 |
$1,123,497 |
D/D |
(2,423) |
1,902 |
|
-0% |
|
Penczek Ronald W |
CAO & Controller |
|
2022-03-03 |
4 |
OE |
$271.27 |
$457,562 |
D/D |
1,559 |
4,325 |
|
- |
|
Norwood Felicia F |
EVP & President, GBD |
|
2022-03-02 |
4 |
D |
$463.49 |
$206,717 |
D/D |
(446) |
28,438 |
|
- |
|
Gallina John E |
EVP & Chief Financial Officer |
|
2022-03-02 |
4 |
GD |
$0.00 |
$0 |
D/D |
1,420 |
56,181 |
|
- |
|
Gallina John E |
EVP & Chief Financial Officer |
|
2022-03-02 |
4 |
D |
$463.49 |
$191,421 |
D/D |
(413) |
57,601 |
|
- |
|
Penczek Ronald W |
CAO & Controller |
|
2022-03-02 |
4 |
D |
$463.49 |
$24,101 |
D/D |
(52) |
2,766 |
|
- |
|
Boudreaux Gail |
President and CEO |
|
2022-03-02 |
4 |
D |
$463.49 |
$762,441 |
D/D |
(1,645) |
120,639 |
|
- |
|
Haytaian Peter D |
EVP & Pres., DBG & IngenioRx |
|
2022-03-02 |
4 |
D |
$463.49 |
$228,501 |
D/D |
(493) |
28,016 |
|
- |
|
Kendrick Charles Morgan Jr |
EVP & President, Commercial |
|
2022-03-02 |
4 |
D |
$463.49 |
$50,984 |
D/D |
(110) |
14,529 |
|
- |
|
Mccarthy Gloria M |
EVP & Chief Administrative Off |
|
2022-03-02 |
4 |
D |
$463.49 |
$225,720 |
D/D |
(487) |
60,731 |
|
- |
|
Norwood Felicia F |
EVP & President, GBD |
|
2022-03-01 |
4 |
A |
$0.00 |
$0 |
D/D |
9,196 |
28,884 |
|
- |
|
Norwood Felicia F |
EVP & President, GBD |
|
2022-03-01 |
4 |
D |
$451.50 |
$1,610,952 |
D/D |
(3,568) |
19,688 |
|
- |
|
633 Records found
|
|
Page 4 of 26 |
|
|